MORGAN HUBELI: Open Payments
NPI 1043885692 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,300 in 190 payments from 25 companies in 2025. Trend: 2023 $1,364 · 2024 $3,219 · 2025 $8,300
Speaker / faculty: $4,450Food & beverage: $3,669Consulting: $101Education: $80
| Company | Payments | Amount |
|---|---|---|
| AYTU BioPharma, Inc. | 33 | $4,741 |
| ARS Pharmaceuticals Operations, Inc. | 24 | $538 |
| AstraZeneca Pharmaceuticals LP | 23 | $509 |
| Regeneron Healthcare Solutions, Inc. | 15 | $401 |
| CSL Behring | 10 | $319 |
| GlaxoSmithKline, LLC. | 23 | $290 |
| Organon LLC | 6 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $174 |
| Pharming Healthcare, Inc. | 3 | $150 |
| PFIZER INC. | 10 | $147 |
Products named: Karbinal, NEFFY, DUPIXENT, Hizentra, FASENRA, TEZSPIRE, TRELEGY ELLIPTA, RUCONEST.
Industry payments across NC — which companies pay providers there.
